Literature DB >> 16624273

Oral phenylalanine loading test for the diagnosis of dominant guanosine triphosphate cyclohydrolase 1 deficiency.

Eduardo López-Laso1, Aida Ormazabal, Rafael Camino, Francisco J Gascón, Juan J Ochoa, María E Mateos, María J Muñoz, Juan L Pérez-Navero, José I Lao, María A Vilaseca, Rafael Artuch.   

Abstract

OBJECTIVES: To evaluate the usefulness of Phe loading test in patients for the diagnosis of guanosine triphosphate cyclohydrolase 1 deficiency (GTPCH). DESIGN AND METHODS: We studied one family composed of 13 members harbouring the Q89X mutation in the GTPCH gene, a non-related pediatric patient with GTPCH deficiency and 8 pediatric controls. 100 mg/kg of L-phenylalanine was orally administered, and blood spot samples were taken at baselines 1, 2, 4 and 6 h post-load.
RESULTS: Two out of 7 pediatric patients showed a phenylalanine/tyrosine ratio higher than the previously reported cut-off value of 5.25 at 4 h, while 6 of the 7 adult patients showed a higher value. The only adult patient with a phenylalanine/tyrosine ratio below 5.25 at 4 h was asymptomatic.
CONCLUSIONS: A cut-off value of 5.25 seems reliable for interpreting Phe loading test in adult patients with GTPCH deficiency, although a lower value should be established for pediatric patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16624273     DOI: 10.1016/j.clinbiochem.2006.03.002

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  6 in total

1.  Urinary neopterin and phenylalanine loading test as tools for the biochemical diagnosis of segawa disease.

Authors:  Vincenzo Leuzzi; Claudia Carducci; Flavia Chiarotti; Daniela D'Agnano; Maria Teresa Giannini; Italo Antonozzi; Carla Carducci
Journal:  JIMD Rep       Date:  2012-04-18

2.  Neuropsychiatric symptoms and intelligence quotient in autosomal dominant Segawa disease.

Authors:  Eduardo López-Laso; Araceli Sánchez-Raya; Juan Antonio Moriana; Eduardo Martínez-Gual; Rafael Camino-León; María Elena Mateos-González; Juan Luis Pérez-Navero; Juan José Ochoa-Sepúlveda; Aida Ormazabal; Thomas Opladen; Christine Klein; José Ignacio Lao-Villadóniga; Katrin Beyer; Rafael Artuch
Journal:  J Neurol       Date:  2011-05-10       Impact factor: 4.849

3.  Dyskinesias as a limiting factor in the treatment of Segawa disease.

Authors:  Eduardo López-Laso; Katrin Beyer; Thomas Opladen; Rafael Artuch; Rachel Saunders-Pullman
Journal:  Pediatr Neurol       Date:  2012-06       Impact factor: 3.372

4.  Genotype-phenotype correlations in sepiapterin reductase deficiency. A splicing defect accounts for a new phenotypic variant.

Authors:  Luisa Arrabal; Libertad Teresa; Rocío Sánchez-Alcudia; Margarita Castro; Celia Medrano; Luis Gutiérrez-Solana; Susana Roldán; Aida Ormazábal; Celia Pérez-Cerdá; Begoña Merinero; Belén Pérez; Rafael Artuch; Magdalena Ugarte; Lourdes R Desviat
Journal:  Neurogenetics       Date:  2011-03-24       Impact factor: 2.660

5.  Phenylalanine loading in pediatric patients with dopa-responsive dystonia: revised test protocol and pediatric cutoff values.

Authors:  Thomas Opladen; Jürgen G Okun; Peter Burgard; Nenad Blau; Georg F Hoffmann
Journal:  J Inherit Metab Dis       Date:  2010-07-29       Impact factor: 4.982

6.  Sepiapterin reductase deficiency in a 2-year-old girl with incomplete response to treatment during short-term follow-up.

Authors:  K Kusmierska; E E W Jansen; C Jakobs; K Szymanska; E Malunowicz; D Meilei; B Thony; N Blau; J Tryfon; D Rokicki; E Pronicka; J Sykut-Cegielska
Journal:  J Inherit Metab Dis       Date:  2009-01-07       Impact factor: 4.982

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.